Physician profile
Stephen Fromel
NPI 1780716811
$1,709.10
in general payments reported to CMS, 2019-2025
9 companies · $402 in 2025
The $402 reported for 2025 was more than what 76% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $139 · 2023: $532 · 2024: $465 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $360.74 | 2023-2024 | Impella |
| Edwards Lifesciences Corporation | $324.98 | 2021-2024 | |
| Cvrx, INC. | $320.42 | 2025 | Barostim Neo System |
| Abbott Laboratories | $306.69 | 2021-2024 | Epic |
| Atricure, INC. | $228.63 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $82.03 | 2025 | Venapax |
| Bolton Medical INC | $51.87 | 2023-2024 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Medtronic, INC. | $25.33 | 2023 | Avalus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Fromel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.